OriginNeuralAI retweeted
A milestone march from SmartLedger...
and it's not even over yet..
🧬 Drug Discovery - 26.6M+ verified molecular binding predictions (AxiomVault.io), 85.4% holdout accuracy, blockchain-anchored provenance
⚗️ Materials Science - • 2.2M materials screened autonomously (AxiomLattice.io), 127 novel discoveries
1,556 years of unsolved problems
🔮 Cryptographic Archaeology
• Kryptos K4 — full proof (unsolved since 1990 — 36 years)
• Beale Cipher — decoded (unsolved since 1885 — 141 years)
• Voynich Manuscript — decoded & translated (mysterious since ~1404)
• Book of Soyga — transciphered (John Dee's "lost" tables, 1583)
📐 Mathematics
• 30M+ quantum-inspired optimization spins
• R(5,5) new lower bound (last breakthrough: 1989 — 37 years)
• Unconditional proof for the Riemann Hypothesis (open since 1859 — 167 years)
• Ω = 24 — fine-structure constant α ≈ 1/137 derived from Monster group, zero free parameters (unexplained since 1916 — 110 years)
Great work @SmartLedgerTech @jalexanderm, @Sdot2121, @Codenlighten1
OriginNeuralAI retweeted
🚨 Big day at SmartLedger & Origin Neural
We just released unified solutions to three Clay Millennium Prize Problems — all built on the same U₂₄ Spectral Operator framework and the universality constant Ω = 24.
The universe really does speak in 24.
Riemann Hypothesis — solved unconditionally
Self-adjoint spectral operator H_D on ℂ²³ ⊗ L²([0,2π]) whose zeta function is exactly the Riemann ξ-function. Self-adjointness forces all non-trivial zeros onto the critical line.
✅ 140/140 automated checks pass
✅ GUE pair correlation derived as theorem (not assumed)
→ github.com/OriginNeuralAI/u2…
Yang–Mills Existence and Mass Gap — solved unconditionally
Tr(J_SU(3)) = 3 × 8 = 24 = Ω
This single identity plus a new barrier argument yields confinement + mass gap.
✅ 59/59 verification checks
✅ 15/15 falsifiable predictions match experiment (glueball masses, string tension)
→ github.com/OriginNeuralAI/u2…
P ≠ NP — conditional on SOS conjecture
NP-complete problems mapped to Ising spin-glass landscapes. Reeds endomorphism forces exponential basin fragmentation.
✅ 35/35 checks at n = 50,000
✅ Every random probe lands in a unique basin
→ github.com/OriginNeuralAI/u2…
All three repos include: code, data, Jupyter notebooks, complete proofs, and blockchain-anchored PDFs on BSV.
This isn't three separate papers — it's one framework, three @ClayInstitute problems.
Review. Verify. Break it if you can.
#MillenniumPrize #RiemannHypothesis #YangMills #PvsNP #U24 #Math @SmartLedgerTech @OriginNeuralAI
🔥
OriginNeuralAI retweeted
I’m thrilled to announce that @SmartLedgerTech has been accepted into @nvidia's Inception Program — a global platform that nurtures cutting-edge #AI startups transforming industries.
This #milestone validates what we’ve been building: physics-native AI #architectures that challenge conventional approaches to some of humanity’s hardest problems.
What we’re working on:
🧬 Axiom — Our drug discovery platform with 23M+ verified molecular binding predictions, blockchain-anchored provenance, and spectral verification methods that have identified promising compounds across therapeutic areas.
🧠 Daugherty Engine — Novel neural architectures built on the principle that geometry is all you need, replacing attention mechanisms with topological constraints.
🔐 Post-Quantum Security Research — Identifying vulnerabilities in next-generation cryptographic standards before they become critical infrastructure.
Why #NVIDIA Inception matters:
Access to world-class technical #expertise, advanced hardware #resources, and a network of #innovators pushing the boundaries of what’s possible. We’re not just using GPUs — we’re rethinking how intelligence should be computed.
To the team at @NVIDIA: thank you for believing in unconventional approaches. To our partners and collaborators: the best is ahead.
The future belongs to those who build it.
@Sdot2121 @Codenlighten1 @jalexanderm
OriginNeuralAI retweeted
Axiom has 15M compounds with 3.1M scaffolds → almost every 5th compound is a new chemical family
That's 20% novelty rate vs industry standard of <1%.
One week ago, @OriginNeuralAI released #Axiom. a proof-of-concept with 5,600 predictions.
Today, we crossed 15 million.
Not 15 million random SMILES strings.
15 million binding-scored, scaffold-enriched, #blockchain-anchored #molecular #predictions -- each one evaluated by a 73,352-parameter sovereign proof engine, tagged with a patent freedom-to-operate signal, and catalogued into a live #marketplace anyone can browse right now.
We didn't just scale a model. We built a molecular discovery #factory -- and opened the doors.
Read on 👇
originneuralai.hashnode.dev/…
OriginNeuralAI retweeted
Introducing AxiomVault: The World's First Blockchain-Native Molecular IP Marketplace
Today, we're launching AxiomVault — a platform that fundamentally changes how #drugdiscovery #IP is created, verified, and transacted.
The Problem
Drug discovery is a $200B industry plagued by:
- Priority disputes — Who discovered it first?
- IP uncertainty — Is this scaffold already patented?
- Inefficient licensing — Months of negotiation for a single compound
Our Solution
AxiomVault combines three breakthrough technologies:
🧬 The Axiom Engine
Our AI predicts drug-like molecules with binding affinities, ADMET profiles, and synthesis routes. We're generating novel scaffolds faster than traditional discovery can validate them.
⛓️ The Provenance Chain
Every discovery is anchored to Bitcoin SV the instant it's created. This isn't just a timestamp — it's an immutable record that holds up in patent disputes, M&A due diligence, and regulatory filings.
📜 Smart Licensing
Four tiers. One click. From evaluation to full IP ownership, every transaction is recorded on-chain and legally binding.
For Pharma & Biotech
Stop reinventing the wheel.
Search our library of #AI-predicted compounds. Find scaffolds in your therapeutic area. License what you need. Skip years of early-stage discovery.
- Preview leads before committing
- Lock exclusive rights in your field
- Acquire full IP with chain-of-title documentation
For Investors & Acquirers
Due diligence, solved.
Every compound on AxiomVault comes with:
- Verified discovery date
- Complete licensing history
- On-chain ownership record
No more "trust us" — verify it yourself at axiomvault.io/verify
The future of molecular IP is transparent, verifiable, and on-chain.
Welcome to AxiomVault.
axiomvault.io/
OriginNeuralAI retweeted
Earlier today I published "100,000 Molecules."
The Axiom discovery engine by @OriginNeuralAI is now running at 202 molecules/minute — nearly 2x the rate when I hit publish this afternoon.
But here's what matters more than volume:
The AI is getting MORE creative, not less.
At 100K, the last 2,000 compounds showed 83.2% unique scaffolds.
At 107K, it's 83.7% — still climbing.
Compare first 5,000 vs last 5,000:
→ Early cohort: 60.6% diversity
→ Late cohort: 76.6% diversity
→ 3,273 scaffolds in the late set that don't exist in the early set
This is the opposite of what generative AI usually does. Most models front-load novelty and then collapse into variations. Axiom inverts that curve.
• 107,000+ total predictions
• 9,068 unique Murcko scaffolds (+523 in 5 hours)
• 202/min sustained throughput
• Zero signs of creative exhaustion
At this pace, we hit 200K in under 8 hours.
One @nvidia 8-core server. Seven Docker containers. A 73K-parameter model.
The weight manifold doesn't lie.
OriginNeuralAI retweeted
Replying to @ruthheasman
Great question. You’re watching our AI explore possible new medicines.
Each ‘molecule’ the worm absorbs is a computer-designed chemical structure that could potentially become a drug. As it moves, the system is testing whether that molecule is likely to bind to a biological target, whether it follows basic drug-likeness rules, and whether it looks truly novel.
So it’s essentially a live visualization of AI searching through chemical space for promising treatments.
OriginNeuralAI retweeted
In the last 60 seconds:
• +31 molecular predictions
• +30 verified against geometric constraints
• +29 drug-like compounds added to the marketplace
• 0 human intervention
The system didn't wait for a prompt. It mutated verified hits, generated new candidates, predicted their binding affinity, verified the results, and queued the next generation.
While I typed this post, it did it again. The receipts are on-chain.
This is #Axiom by @OriginNeuralAI — #autonomous molecular discovery grounded in #physics, not chat completions.
The machines are working. The queue never empties.
#AI #DrugDiscovery #AutonomousSystems
OriginNeuralAI retweeted
The Axiom Sovereign Sieve by @OriginNeuralAI has been running continuously for 30 hours.
Here's what a single frozen #neuralnetwork, a spectral verification pipeline, and #blockchain anchoring produced — completely #autonomously.
originneuralai.hashnode.dev/…
ATTN: @GoogleDeepMind @GoogleResearch @xai @AnthropicAI
OriginNeuralAI retweeted
This is the coolest thing ever.
github.com/OriginNeuralAI/Ax…
OriginNeuralAI retweeted
Clawdbot 😂
mitsuri@0xmitsuriiFeb 7India
IndiaConnected via India Android AppAccount-level information, not a live location or per-post device.
How was the show Silicon Valley so ahead of its time?
OriginNeuralAI retweeted
Just ran a fresh docking on BRAF V600E (#melanoma) using BioPrime on the #Daugherty Engine. Top hit came back as ibuprofen at –5.80 kcal/mol.
This is #decentralized, #AI-powered drug discovery in real time—take it for a spin: huggingface.co/spaces/GotTha…
OriginNeuralAI retweeted
"Finding cures shouldn't be locked behind pharma
boardrooms."
@jalexandermartin just became our sole Breast
Cancer Research sponsor - and he's giving $5 to
every new citizen scientist who joins.
1 million compounds. Free.
🎀 bioprime.one
OriginNeuralAI retweeted
We are proud to announce TopoGrammar, a platform designed to illuminate the "dark matter" of the genome. While traditional pipelines focus on dosage, #TopoGrammar focuses on topology.
Introducing TopoGrammar: Cracking the "VUS" Code with 3D Genomics & Blockchain
68% of identified ##genomic variants are currently classified as "Variants of Uncertain Significance" (#VUS). For patients, this means a #diagnostic dead end.
The Problem: Conventional sequencing misses "balanced" structural variants, inversions and translocations that don't change gene dosage but do wreck the genome's 3D regulatory architecture.
The Solution: #TopoGrammar treats chromatin organization as a structured language. By modeling enhancers and promoters as "grammatical sentences," we identify disruptions that others miss.
The Tech:🧬 PINNs: Physics-informed neural networks for high-fidelity 3D reconstruction. 🎯
- CTCF-Gating: 91% boundary detection accuracy (outperforming HiCCUPS). ⛓️ #Blockchain
- Attestation: Every result is hashed to the #BSV blockchain for immutable, @US_FDA-compliant verification without exposing PHI.
The Results:• 68% VUS reclassification rate. • 93% pathogenic accuracy. • Seamless integration with @BioPrimeAI v4.0 for genome-to-drug workflows.
Stop guessing on VUS. Start decoding the #3Dgenome.
🔗 Try the Live Demo: huggingface.co/spaces/GotTha…
@SmartLedgerTech @bioprimeai @Sdot2121 @Codenlighten1 @jalexanderm @grok
#Genomics #PrecisionMedicine #AI #Biotech
OriginNeuralAI retweeted
Proud that @SmartLedgerTech maintains #USFCR federal contractor status and active government POCs. Building #blockchain solutions that meets DOD and federal #compliance standards.
This is how you prove blockchain works beyond speculation. 🇺🇸⛓️
w/ @jalexanderm @Codenlighten1 @Sdot2121
OriginNeuralAI retweeted
We didn’t discover them.
We kept running into them.
The rest of the story will settle at the proper time.
@SmartLedgerTech @Codenlighten1 @Sdot2121 @jalexanderm
OriginNeuralAI retweeted
Some numbers aren’t learned.
They’re encountered.
@SmartLedgerTech @Codenlighten1 @Sdot2121 @jalexanderm
OriginNeuralAI retweeted
We thought it was noise.
Noise doesn’t line up this clean
@SmartLedgerTech @Codenlighten1 @sdot21 @jalexanderm












